Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The Biochemical Journal|November 1, 1992
Site-directed mutagenesis of the leech-derived factor Xa inhibitor antistasin. Probing of the reactive siteK J Hofmann, E M Nutt, C T Dunwiddie
Archives of Biochemistry and Biophysics|May 1, 1992
The hydrolysis and resynthesis of a single reactive site peptide bond in recombinant antistasin by coagulation factor XaC T Dunwiddie, G P Vlasuk, E M Nutt
Thrombosis and Haemostasis|May 6, 1991
Cellular localization of activated factor X by Xa-specific probesL R Zacharski, C Dunwiddie, E M Nutt, et al.
Thrombosis and Haemostasis|March 2, 1992
Anticoagulant efficacy and immunogenicity of the selective factor Xa inhibitor antistasin following subcutaneous administration in the rhesus monkeyC T Dunwiddie, E M Nutt, G P Vlasuk, et al.
The Journal of Biological Chemistry|November 20, 1997
The alphavbeta3 integrin regulates alpha5beta1-mediated cell migration toward fibronectinK O Simon, E M Nutt, D G Abraham, et al.
Archives of Biochemistry and Biophysics|February 15, 1991
Purification and characterization of recombinant antistasin: a leech-derived inhibitor of coagulation factor XaE M Nutt, D Jain, A B Lenny, et al.
Molecular Pharmacology|August 1, 1997
Arginine-glycine-aspartic acid mimics can identify a transitional activation state of recombinant alphaIIb beta3 in human embryonic kidney 293 cellsD G Abraham, E M Nutt, R A Bednar, et al.
Thrombosis and Haemostasis|March 4, 1991
Comparison of the in vivo anticoagulant properties of standard heparin and the highly selective factor Xa inhibitors antistasin and tick anticoagulant peptide (TAP) in a rabbit model of venous thrombosisG P Vlasuk, D Ramjit, T Fujita, et al.
Journal of Cardiovascular Pharmacology|February 1, 1995
Comparison of binding to rapidly activating delayed rectifier K+ channel, IKr, and effects on myocardial refractoriness for class III antiarrhythmic agentsJ J Lynch, E P Baskin, E M Nutt, et al.
Cardiovascular Research|January 1, 1994
Maintenance of canine coronary artery patency following thrombolysis with front loaded plus low dose maintenance conjunctive therapy. A comparison of factor Xa versus thrombin inhibitionJ J Lynch, G R Sitko, M J Mellott, et al.
Pageof 2